Metraipolis › archive › dc_e2444ecb886a

Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and… — Europe PMC PMID:42356044

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42356044
DOI
10.3390/medicina62061031
License (as archived)
solo-consultazione
Archived
2026-11-01T07:29:51.686Z
SHA-256 of the archived text
95f5b36faa5310b0b407f62a18457988e1993bf606294902e711fb3a1f5b367b
Stable URL of this page
https://metraipolis.com/documento/dc_e2444ecb886a

How to cite

Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and… — Europe PMC PMID:42356044 — Europe PMC (en), https://europepmc.org/article/MED/42356044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2444ecb886a (Metraipolis archive dc_e2444ecb886a, sha256 95f5b36faa5310b0b407f62a18457988e1993bf606294902e711fb3a1f5b367b)
BibTeX
@misc{dce2444ecb886a,
  title = {Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and… — Europe PMC PMID:42356044},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42356044},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2444ecb886a; sha256 95f5b36faa5310b0b407f62a18457988e1993bf606294902e711fb3a1f5b367b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42356044. Agents can read the archived copy with the MCP tool read_document.